GENE ONLINE|News &
Opinion
Blog

Molnupiravir
Trials & Approvals FDA
FDA Gives Emergency Approval to Merck’s COVID-19 Pill after Giving Similar Nod to Pfizer’s Tablets
2021-12-24
COVID-19 COVID-19 Pill
Updated Trial Data Shows Lower Efficacy for Merck’s Oral COVID-19 Pill
2021-11-26
COVID-19 Molnupiravir
Singapore Becomes Latest Asian Country to Sign Merck Deal for Oral COVID-19 Pill
2021-10-06
COVID-19 Antiviral
Merck Announces Its Oral COVID-19 Drug Cuts Risk of Hospitalization and Death by 50%
2021-10-01
COVID-19 Remdesivir
As India Suffers Crisis, Merck Signs License Pact with 5 Indian Firms to Manufacture COVID-19 Drugs
2021-04-29
COVID-19 Anti-COVID Drug
Merck Says Preliminary Trial Findings of Oral COVID-19 Drug Encouraging
2021-03-08
LATEST
Core8 Group and MedArmor to Pioneer Vietnam’s First AI x ESG Hospital
2024-12-10
The Future of Generative AI for New Drug Development and Precision Medicine
2024-12-09
How FIRM is Shaping Regenerative Medicine in Japan
2024-12-09
AI, Smart Tech, and ICT to Unite the Global Biotech and Healthcare Industries in 2025
2024-12-06
Core8 Group to Establish Vietnam’s First Comprehensive Biotechnology Incubator
2024-12-05
Ono Enters into Drug Discovery Collaboration Agreement with Congruence Therapeutics to Generate Novel Small Molecule Correctors in the Oncology Area
2024-12-05
Ipsen Bets $600M on Biomunex’s First-in-Class T-Cell Engager BMX-502
2024-12-03
READ MORE
EVENT
SEE MORE
Newsletter

Subscribe to receive updates.

SIGN UP
Facebook
Youtube
Twitter
Linkedin
About
Explore
More
© 2024 GeneOnline
Privacy Policy | Terms of Service
Privacy Policy | Terms of Service
  • Subscribe to our newsletter and dive into the world of biopharma with us.
SIGN UP
x
Scroll to Top